Second Test Backs Single Dose of Glaxo H1N1 Shot

GlaxoSmithKline said on Friday a second clinical trial of its adjuvanted H1N1 swine flu vaccine Pandemrix had confirmed that a single dose could provide a strong immune response. Reuters Health Information (Source: Medscape Medical News Headlines) Read The Full Story


Related posts



1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading ... Loading ...

Tags: , , , ,

permalinkRead More CommentComments (0) CatSwine Flu Feeds

Leave a Reply